Brind.
  1. Xilio Therapeutics shares underperformed the S&P 500 so far this year, based on events of August 14, 2025.

Raymond James Financial assumed coverage on Xilio Therapeutics shares.

1 report, 1 independent Updated 00:00
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Raymond James Financial assumed coverage on Xilio Therapeutics shares.

Who's involved

What this event is mainly about

Keep exploring

The entities involved

Related events

Coverage

Newest first; wire copies grouped